Literature DB >> 36200025

Need for revision of the ACMG/AMP guidelines for interpretation of X-linked variants.

Yoko Inoue1,2, Osamu Machida1,3, Yosuke Kita4, Toshiyuki Yamamoto1,2.   

Abstract

The guidelines provided by American College of Medical Genetics and Genomics (ACMG) and the Association of Molecular Pathology (AMP) (ACMG/AMP guidelines) suggest a framework for the classification of clinical variants. However, the interpretations can be inconsistent, with each definition sometimes proving to be ambiguous. In particular, there can be difficulty with interpretation of variants related to the X-linked recessive trait. To confirm whether there are biases in the interpretation of inherited traits, we reanalyzed variants reported prior to the release of the ACMG/AMP guidelines. As expected, the interpretation ratio as pathogenic or likely pathogenic was significantly lower for variants related to the X-linked recessive trait. Evaluation of variants related to the X-linked recessive trait, hence, need to consider whether the variant is identified only in males in accordance with the X-linked recessive trait. The ACMG/AMP guidelines should be revised to eliminate the bias revealed in this study. 2022, International Research and Cooperation Association for Bio & Socio - Sciences Advancement.

Entities:  

Keywords:  ACMG/AMP guidelines; X-linked recessive; diagnostic odyssey; interpretation; sequence variant

Year:  2022        PMID: 36200025      PMCID: PMC9437996          DOI: 10.5582/irdr.2022.01067

Source DB:  PubMed          Journal:  Intractable Rare Dis Res        ISSN: 2186-3644


  47 in total

1.  Mutations in NSD1 are responsible for Sotos syndrome, but are not a frequent finding in other overgrowth phenotypes.

Authors:  Seval Türkmen; Gabriele Gillessen-Kaesbach; Peter Meinecke; Beate Albrecht; Luitgard M Neumann; Volker Hesse; Sükrü Palanduz; Stefanie Balg; Frank Majewski; Sigrun Fuchs; Petra Zschieschang; Monika Greiwe; Kirsten Mennicke; Friedmar R Kreuz; Harald J Dehmel; Burkhard Rodeck; Jürgen Kunze; Sigrid Tinschert; Stefan Mundlos; Denise Horn
Journal:  Eur J Hum Genet       Date:  2003-11       Impact factor: 4.246

2.  Genomic backgrounds of Japanese patients with undiagnosed neurodevelopmental disorders.

Authors:  Toshiyuki Yamamoto; Taichi Imaizumi; Keiko Yamamoto-Shimojima; Yongping Lu; Tomoe Yanagishita; Shino Shimada; Pin Fee Chong; Ryutaro Kira; Riyo Ueda; Akihiko Ishiyama; Eri Takeshita; Ken Momosaki; Shiro Ozasa; Tomoyuki Akiyama; Katsuhiro Kobayashi; Hiroo Oomatsu; Hikaru Kitahara; Tokito Yamaguchi; Katsumi Imai; Hirokazu Kurahashi; Akihisa Okumura; Hirokazu Oguni; Toshiyuki Seto; Nobuhiko Okamoto
Journal:  Brain Dev       Date:  2019-06-04       Impact factor: 1.961

Review 3.  Challenges in molecular diagnosis of X-linked Intellectual disability.

Authors:  Chiara De Luca; Valérie Race; Liesbeth Keldermans; Marijke Bauters; Hilde Van Esch
Journal:  Br Med Bull       Date:  2020-05-15       Impact factor: 4.291

4.  Loss of function in phenylketonuria is caused by impaired molecular motions and conformational instability.

Authors:  Søren W Gersting; Kristina F Kemter; Michael Staudigl; Dunja D Messing; Marta K Danecka; Florian B Lagler; Christian P Sommerhoff; Adelbert A Roscher; Ania C Muntau
Journal:  Am J Hum Genet       Date:  2008-06-05       Impact factor: 11.025

5.  A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir-Torre variant of Lynch syndrome.

Authors:  Maegan E Roberts; Douglas L Riegert-Johnson; Brittany C Thomas; Kandelaria M Rumilla; Colleen S Thomas; Michael G Heckman; Jennifer U Purcell; Nancy B Hanson; Kathleen A Leppig; Justin Lim; Mark A Cappel
Journal:  Genet Med       Date:  2014-03-06       Impact factor: 8.822

6.  Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders.

Authors:  Brian J O'Roak; Laura Vives; Wenqing Fu; Jarrett D Egertson; Ian B Stanaway; Ian G Phelps; Gemma Carvill; Akash Kumar; Choli Lee; Katy Ankenman; Jeff Munson; Joseph B Hiatt; Emily H Turner; Roie Levy; Diana R O'Day; Niklas Krumm; Bradley P Coe; Beth K Martin; Elhanan Borenstein; Deborah A Nickerson; Heather C Mefford; Dan Doherty; Joshua M Akey; Raphael Bernier; Evan E Eichler; Jay Shendure
Journal:  Science       Date:  2012-11-15       Impact factor: 47.728

7.  Adaptation and validation of the ACMG/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen's Inherited Cardiomyopathy Expert Panel.

Authors:  Melissa A Kelly; Colleen Caleshu; Ana Morales; Jillian Buchan; Zena Wolf; Steven M Harrison; Stuart Cook; Mitchell W Dillon; John Garcia; Eden Haverfield; Jan D H Jongbloed; Daniela Macaya; Arjun Manrai; Kate Orland; Gabriele Richard; Katherine Spoonamore; Matthew Thomas; Kate Thomson; Lisa M Vincent; Roddy Walsh; Hugh Watkins; Nicola Whiffin; Jodie Ingles; J Peter van Tintelen; Christopher Semsarian; James S Ware; Ray Hershberger; Birgit Funke
Journal:  Genet Med       Date:  2018-01-04       Impact factor: 8.822

8.  ClinGen's RASopathy Expert Panel consensus methods for variant interpretation.

Authors:  Bruce D Gelb; Hélène Cavé; Mitchell W Dillon; Karen W Gripp; Jennifer A Lee; Heather Mason-Suares; Katherine A Rauen; Bradley Williams; Martin Zenker; Lisa M Vincent
Journal:  Genet Med       Date:  2018-03-01       Impact factor: 8.822

9.  Six years' accomplishment of the Initiative on Rare and Undiagnosed Diseases: nationwide project in Japan to discover causes, mechanisms, and cures.

Authors:  Yuji Takahashi; Hidetoshi Date; Hideki Oi; Takeya Adachi; Noriaki Imanishi; En Kimura; Hotake Takizawa; Shinji Kosugi; Naomichi Matsumoto; Kenjiro Kosaki; Yoichi Matsubara; Hidehiro Mizusawa
Journal:  J Hum Genet       Date:  2022-03-23       Impact factor: 3.755

10.  Disease-specific ACMG/AMP guidelines improve sequence variant interpretation for hearing loss.

Authors:  Mayher J Patel; Marina T DiStefano; Andrea M Oza; Madeline Y Hughes; Emma H Wilcox; Sarah E Hemphill; Brandon J Cushman; Andrew R Grant; Rebecca K Siegert; Jun Shen; Alex Chapin; Nicole J Boczek; Lisa A Schimmenti; Kiyomitsu Nara; Margaret Kenna; Hela Azaiez; Kevin T Booth; Karen B Avraham; Hannie Kremer; Andrew J Griffith; Heidi L Rehm; Sami S Amr; Ahmad N Abou Tayoun
Journal:  Genet Med       Date:  2021-07-06       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.